Elite Pharmaceuticals, Inc. financial statements
Elite Pharmaceuticals, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2026
| Revenue | USD 148.87M | 10-K |
| Net income | USD 44.87M | 10-K |
| Cash and equivalents | USD 29.8M | 10-Q |
Elite Pharmaceuticals, Inc. financials on 6ix · Elite Pharmaceuticals, Inc. on 6ix